Amniotic membrane transplantation in the management of severe ocular surface disease: indications and outcomes.
about
The ocular surface chemical burnsConstitutive expression of pentraxin 3 (PTX3) protein by human amniotic membrane cells leads to formation of the heavy chain (HC)-hyaluronan (HA)-PTX3 complex.Reversal of myofibroblasts by amniotic membrane stromal extract.Sutureless amniotic membrane transplantation for severe bacterial keratitis.Temporary sutureless amniotic membrane patch for acute alkaline burns.Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis.Update on amniotic membrane transplantationInhibition of angiogenesis by HC·HA, a complex of hyaluronan and the heavy chain of inter-α-inhibitor, purified from human amniotic membraneNiche regulation of corneal epithelial stem cells at the limbus.Cellular response of limbal epithelial cells on electrospun poly-ε-caprolactone nanofibrous scaffolds for ocular surface bioengineering: a preliminary in vitro study.Sutureless fixation of amniotic membrane for therapy of ocular surface disorders.Constitutive expression of inter-α-inhibitor (IαI) family proteins and tumor necrosis factor-stimulated gene-6 (TSG-6) by human amniotic membrane epithelial and stromal cells supporting formation of the heavy chain-hyaluronan (HC-HA) complex.Suppression of activation and induction of apoptosis in RAW264.7 cells by amniotic membrane extract.Immobilized heavy chain-hyaluronic acid polarizes lipopolysaccharide-activated macrophages toward M2 phenotypeNeurological Outcomes after Human Umbilical Cord Patch for In Utero Spina Bifida Repair in a Sheep ModelBiochemical characterization and function of complexes formed by hyaluronan and the heavy chains of inter-alpha-inhibitor (HC*HA) purified from extracts of human amniotic membrane.Current and Upcoming Therapies for Ocular Surface Chemical Injuries.Efficacy of self-retained cryopreserved amniotic membrane for treatment of neuropathic corneal pain.Management of a neurotrophic deep corneal ulcer with amniotic membrane transplantation in a patient with functional monocular vision: A case report.
P2860
Q27023821-09B7C145-BE8E-44A3-AEC4-A70FCD41711EQ33676745-E7550E02-8133-48A6-BEDD-34C3897739DEQ33732006-A20E7F94-A6E8-4B5D-B5FB-09B9FF90EDB4Q33755631-255ECDAA-1A25-4DBB-8CCE-D3A46D4BBF1CQ33767913-1437F0F8-DA76-465F-8569-BD64BC72748BQ33786399-AD15D100-5628-496D-BB13-CD51AF5AC145Q34173270-DF21AC84-89CB-49C8-9B58-72104D5507F9Q34936950-218B1224-659E-4070-948F-25D664E2D2C5Q35302474-8AA81099-192E-4832-9BE3-3ED9B1EFE9ADQ35575086-4089DB81-A708-4819-AC6D-C97B92D3CC87Q35587121-7A8C3E21-2BF0-4201-B7CE-9888F3F78613Q35874524-0AE34400-6A3B-4A8B-84B8-953E7F1E6EAEQ36946729-3BADBE27-7209-4E1A-8769-F0C8F8E2AA86Q37150998-2CD5E1EE-5A46-44D7-9F3F-10423106AB90Q37245737-669A2781-6746-45AD-91AC-308B00892AFAQ37339027-7AEFAF4C-9A9D-4DD0-926F-948CCB87BCA7Q38819339-20295BE1-E7DC-420E-B3DB-C42B3CE29B31Q47444216-3E8D713B-1222-4BAB-88A7-9E61E7D1DD9AQ49487916-D5969A2E-A634-4E61-AB2F-280FE5294ABA
P2860
Amniotic membrane transplantation in the management of severe ocular surface disease: indications and outcomes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Amniotic membrane transplantat ...... ase: indications and outcomes.
@ast
Amniotic membrane transplantat ...... ase: indications and outcomes.
@en
type
label
Amniotic membrane transplantat ...... ase: indications and outcomes.
@ast
Amniotic membrane transplantat ...... ase: indications and outcomes.
@en
prefLabel
Amniotic membrane transplantat ...... ase: indications and outcomes.
@ast
Amniotic membrane transplantat ...... ase: indications and outcomes.
@en
P1433
P1476
Amniotic membrane transplantat ...... ease: indications and outcomes
@en
P2093
Charles S Bouchard
Thomas John
P304
P356
10.1016/S1542-0124(12)70062-9
P577
2004-07-01T00:00:00Z